Literature DB >> 19937932

Estimation of renal function in patients with chronic kidney disease.

Jeroen P Kooman1.   

Abstract

The risk of nephrogenic systemic fibrosis after gadolinium exposure is inversely related to renal function. Various methods are available to assess the glomerular filtration rate (GFR). Prediction formulas based on serum creatinine, such as the abbreviated Modification of Diet in Renal Disease (MDRD) formula, are most commonly used and appear acceptable for clinical purposes in the majority of patients with chronic renal failure. However, especially in patients at the extremes of body composition, the results from creatinine-based equations should be interpreted with caution. In those patients, additional methods, such as timed urine collections, predictions based on cystatin, single-shot radiotracer methods, or, optimally, inulin clearance could be considered. In this review, the strengths and limitations of different methods to assess GFR are discussed. Apart from inulin clearance, no method can be considered the gold standard in the assessment of GFR. In cases of doubt, the decision to use gadolinium-enhanced magnetic resonance imaging should always be based on clinical risk-benefit judgment. J. Magn. Reson. Imaging 2009;30:1341-1346. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19937932     DOI: 10.1002/jmri.21970

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  10 in total

1.  Renal complications in multiple myeloma and related disorders: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

Authors:  Beth M Faiman; Patricia Mangan; Jacy Spong; Joseph D Tariman
Journal:  Clin J Oncol Nurs       Date:  2011-08       Impact factor: 1.027

2.  Routine determination of GFR in renal transplant recipients by HPLC quantification of plasma iohexol concentrations and comparison with estimated GFR.

Authors:  Stéphanie Castagnet; Hélène Blasco; Patrick Vourc'h; Isabelle Benz-De-Bretagne; Charlotte Veyrat-Durebex; Christelle Barbet; Azmi Alnajjar; Bénédicte Ribourtout; Matthias Buchler; Jean-Michel Halimi; Christian R Andres
Journal:  J Clin Lab Anal       Date:  2012-09       Impact factor: 2.352

3.  Evidence of tubular damage in the very early stage of chronic kidney disease of uncertain etiology in the North Central Province of Sri Lanka: a cross-sectional study.

Authors:  Shanika Nanayakkara; S T M L D Senevirathna; Upul Karunaratne; Rohana Chandrajith; Kouji H Harada; Toshiaki Hitomi; Takao Watanabe; Tilak Abeysekera; T N C Aturaliya; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2011-06-28       Impact factor: 3.674

4.  Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka.

Authors:  Shanika Nanayakkara; Toshiyuki Komiya; Neelakanthi Ratnatunga; S T M L D Senevirathna; Kouji H Harada; Toshiaki Hitomi; Glenda Gobe; Eri Muso; Tilak Abeysekera; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2011-10-13       Impact factor: 3.674

5.  Protective role of antithrombin III in suppressing acute responses in a rat model of renal ischemia-reperfusion injury.

Authors:  Alena Firdus; Nesina Avdagić; Muhamed Fočak; Maja Mitrašinović-Brulić; Damir Suljević
Journal:  Mol Cell Biochem       Date:  2022-01-05       Impact factor: 3.396

6.  Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan.

Authors:  Masaharu Tamaki; Hideki Nakasone; Ayumi Gomyo; Jin Hayakawa; Yu Akahoshi; Naonori Harada; Machiko Kusuda; Yuko Ishihara; Koji Kawamura; Aki Tanihara; Miki Sato; Kiriko Terasako-Saito; Kazuaki Kameda; Hidenori Wada; Misato Kikuchi; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2018-07-23       Impact factor: 2.490

7.  Chronic kidney disease in adolescent and adult patients with phenylketonuria.

Authors:  Julia B Hennermann; Sylvia Roloff; Jutta Gellermann; Ilka Vollmer; Elke Windt; Barbara Vetter; Ursula Plöckinger; Eberhard Mönch; Uwe Querfeld
Journal:  J Inherit Metab Dis       Date:  2012-11-09       Impact factor: 4.982

8.  Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option.

Authors:  I Lazana; L Floro; T Christmas; S Shah; K Bramham; K Cuthill; P Bassett; S Schey; M Kazmi; V Potter; A Pagliuca; M Streetly; R Benjamin
Journal:  Bone Marrow Transplant       Date:  2022-04-12       Impact factor: 5.174

9.  Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma.

Authors:  R Khan; S Apewokin; M Grazziutti; S Yaccoby; J Epstein; F van Rhee; A Rosenthal; S Waheed; S Usmani; S Atrash; S Kumar; A Hoering; J Crowley; J D Shaughnessy; B Barlogie
Journal:  Leukemia       Date:  2012-02-02       Impact factor: 11.528

10.  The Association between Glomerular Filtration Rate Estimated on Admission and Acute Stroke Outcome: The Shiga Stroke Registry.

Authors:  Aryandhito Widhi Nugroho; Hisatomi Arima; Itsuko Miyazawa; Takako Fujii; Naomi Miyamatsu; Yoshihisa Sugimoto; Satoru Nagata; Masaru Komori; Naoyuki Takashima; Yoshikuni Kita; Katsuyuki Miura; Kazuhiko Nozaki
Journal:  J Atheroscler Thromb       Date:  2018-01-19       Impact factor: 4.928

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.